4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-155516
SVP & Chief Scientific Officer acquired 17,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Doberstein Stephen K · SVP & Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-12-13 | Grant or award : show line 1 in the form | +17,500 | 35,765 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-12-13 | Grant or award : show line 2 in the form Stock Option | +43,750 | $12.24 | 2024-12-12 | 43,750 | 43,750 | D |
Loading xslF345X03/doc4.xml…